Your browser doesn't support javascript.
loading
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Pecquet, Christian; Papadopoulos, Nicolas; Balligand, Thomas; Chachoua, Ilyas; Tisserand, Amandine; Vertenoeil, Gaëlle; Nédélec, Audrey; Vertommen, Didier; Roy, Anita; Marty, Caroline; Nivarthi, Harini; Defour, Jean-Philippe; El-Khoury, Mira; Hug, Eva; Majoros, Andrea; Xu, Erica; Zagrijtschuk, Oleh; Fertig, Tudor E; Marta, Daciana S; Gisslinger, Heinz; Gisslinger, Bettina; Schalling, Martin; Casetti, Ilaria; Rumi, Elisa; Pietra, Daniela; Cavalloni, Chiara; Arcaini, Luca; Cazzola, Mario; Komatsu, Norio; Kihara, Yoshihiko; Sunami, Yoshitaka; Edahiro, Yoko; Araki, Marito; Lesyk, Roman; Buxhofer-Ausch, Veronika; Heibl, Sonja; Pasquier, Florence; Havelange, Violaine; Plo, Isabelle; Vainchenker, William; Kralovics, Robert; Constantinescu, Stefan N.
Afiliação
  • Pecquet C; Ludwig Cancer Research, Brussels, Belgium.
  • Papadopoulos N; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Balligand T; Ludwig Cancer Research, Brussels, Belgium.
  • Chachoua I; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Tisserand A; Ludwig Cancer Research, Brussels, Belgium.
  • Vertenoeil G; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Nédélec A; Ludwig Cancer Research, Brussels, Belgium.
  • Vertommen D; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Roy A; Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
  • Marty C; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.
  • Nivarthi H; Université Paris Cité, UMR 1287, Gustave Roussy, Villejuif, France.
  • Defour JP; UMR 1287, Gustave Roussy, Villejuif, France.
  • El-Khoury M; Ludwig Cancer Research, Brussels, Belgium.
  • Hug E; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Majoros A; Ludwig Cancer Research, Brussels, Belgium.
  • Xu E; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Zagrijtschuk O; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Fertig TE; Ludwig Cancer Research, Brussels, Belgium.
  • Marta DS; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Gisslinger H; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.
  • Gisslinger B; UMR 1287, Gustave Roussy, Villejuif, France.
  • Schalling M; Université Paris-Saclay, UMR 1287, Gustave Roussy, Villejuif, France.
  • Casetti I; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
  • Rumi E; Ludwig Cancer Research, Brussels, Belgium.
  • Pietra D; Université Catholique de Louvain and de Duve Institute, SIGN Unit, Brussels, Belgium.
  • Cavalloni C; INSERM, Unité Mixte de Recherche (UMR) 1287, Gustave Roussy, Villejuif, France.
  • Arcaini L; UMR 1287, Gustave Roussy, Villejuif, France.
  • Cazzola M; Université Paris-Saclay, UMR 1287, Gustave Roussy, Villejuif, France.
  • Komatsu N; MyeloPro Diagnostics and Research GmbH, Vienna, Austria.
  • Kihara Y; MyeloPro Diagnostics and Research GmbH, Vienna, Austria.
  • Sunami Y; MyeloPro Diagnostics and Research GmbH, Vienna, Austria.
  • Edahiro Y; MyeloPro Diagnostics and Research GmbH, Vienna, Austria.
  • Araki M; MyeloPro Diagnostics and Research GmbH, Vienna, Austria.
  • Lesyk R; Ultrastructural Pathology Lab and Bioimaging, Institute of Pathology Victor Babeș, Bucharest, Romania.
  • Buxhofer-Ausch V; Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.
  • Heibl S; Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.
  • Pasquier F; Division of Hematology and Blood Coagulation, Department of Internal Medicine I, Division of Hematology and Blood Coagulation, Medical University of Vienna, Vienna, Austria.
  • Havelange V; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
  • Plo I; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
  • Vainchenker W; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
  • Kralovics R; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
  • Constantinescu SN; Division of Hematology, Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy.
Blood ; 141(8): 917-929, 2023 02 23.
Article em En | MEDLINE | ID: mdl-36356299

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Mieloproliferativos / Neoplasias Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article